BioPharmSignal logoBioPharmSignal

Biotech News

Alvotech to Present at Upcoming Investor Conferences in November

Alvotech (ALVO)AlvotechCompany update

REYKJAVIK, ICELAND (November 2, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that members of the management team will participate in upcoming investor conferences in November as follows:

Related news

ALVOAlvotech2026-08-27 12:00 EST

Alvotech to present at upcoming investor conferences in September

ALVOAlvotech2026-10-28 11:00 EST

Alvotech to Report Financial Results for the Nine-Month Period to September 30, 2026

ANIPANI Pharmaceuticals2026-11-03 11:55 EST

ANI Pharmaceuticals to Present at Upcoming November Investor Conferences

MDXGMiMedx2026-11-06 13:00 EST

MIMEDX to Participate in Upcoming Investor Conferences

IBIOIbio Inc2026-11-02 21:30 EST

iBio to Participate in Upcoming Investor Conferences

CHRSCoherus BioSciences, Inc.2026-10-27 13:30 EST

Coherus to Participate in Upcoming Investor Conferences

ANIPANI Pharmaceuticals2026-09-03 10:55 EST

ANI Pharmaceuticals to Present at September Investor Conferences

STTKShattuck Labs2026-09-02 20:05 EST

Shattuck Labs Announces Participation in Upcoming September Investor Conferences

ENTXEntera Bio2026-08-27 13:44 EST

Correction: Entera to Participate in Upcoming Fall Investor Conferences

ENTXEntera Bio2026-08-27 12:00 EST

Entera to Participate in Upcoming Fall Investor Conferences

View all latest news

Alvotech

Global Biosimilar Developer and Manufacturer Alvotech is a biotechnology company focused exclusively on developing and manufacturing biosimilar medicines. It operates an integrated model covering cell-line development, process development, clinical studies, regulatory submissions, commercial-scale manufacturing, and supply to regional...

Recent company news

ALVOAlvotech2026-11-02 12:00 EST

Alvotech to Present at Upcoming Investor Conferences in November

ALVOAlvotech2026-10-28 11:00 EST

Alvotech birtir uppgjör fyrstu níu mánaða ársins 2026 þann 11. nóvember nk.

ALVOAlvotech2026-10-28 11:00 EST

Alvotech to Report Financial Results for the Nine-Month Period to September 30, 2026

ALVOAlvotech2026-10-20 08:30 EST

Lyfjastofnun Bandaríkjanna samþykkir nýja framleiðsluaðferð Alvotech sem rúmlega tvöfaldar afköst við framleiðslu á Simlandi

ALVOAlvotech2026-10-14 08:30 EST

Alvotech og Advanz Pharma fyrst til að sækja um markaðsleyfi fyrir hliðstæðu við augnlyfið Eylea í háum styrk

Stock data

Close
4.55 USD
Market cap
936.14M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States